
News|Articles|January 2, 2024
Reducing Risk in Bioproduction with Facilities Equivalency (Jan 2024)
Author(s)Thermo Fisher Scientific
Media manufacturers must offer global redundancy at harmonized manufacturing facilities to enable streamlined capabilities–especially for their customers outsourcing proprietary cell culture media formulations. This paper details Thermo Fisher’s manufacturing equivalency approach utilized at two global facilities located in Miami, Florida, and Grand Island, New York.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Jubilant Biosys Announces New Facility in India
2
Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference
3
Gene Therapy, Rare Diseases, and Transfer RNA
4
Personalized Medicine Vs. Precision Medicine
5